EXOSENS PROM

Exosens and its subsidiaries develop, manufacture, and sell electro-optical technologies across France, Europe, North America, Asia, and other international markets. The company operates in two segments: Amplification and Detection and Imaging. Its products include image intensifier tubes, cameras, sensors, modules, imaging systems, and detection products for ions, electrons, photons, and neutrons, as well as micro pore optics and components. It sells under the Exosens, Photonis, Xenics, Telops, El-Mul, and Noxant brands and serves defense and surveillance, life sciences and environment, industrial control, and nuclear markets. Founded in 1937, it is headquartered in Mérignac, France.

Defense & Geopolitical Fragmentation▲

Exosens expects 2026 results at upper end of guidance after strong first half

Exosens now expects full-year 2026 revenue and adjusted EBITDA to be towards the upper end of their respective guidance ranges of €520 million to €540 million and €168 million to €178 million, following a strong first half. Revenue rose 15.3% to €253.1 million in the first six months of 2026, with like-for-like growth of 11.4%, driven by accelerating demand for advanced defense imaging and night vision solutions. Adjusted EBITDA reached a record €83.6 million, up 18.3%, pushing the margin to 33.0%. The Amplification segment grew 11.6% to €176.3 million, while Detection & Imaging surged 24.3% to €77.4 million, supported by drone, counter-drone and long-range surveillance applications. The company is expanding production capacity in Europe and the U.S., secured a U.S. Army BiNOD contract, and completed the acquisition of quantum-dot sensor specialist Emberion.

EXENS.PA ▲

Defense & Geopolitical Fragmentation ▲

GlobeNewswire·53dRead more →